相关实验视频

Updated: May 1, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

预测性肺和脏向mRNA交付与可生物降解的电离性脂质在四组分LNP中的四组分LNP

Juan Heredero¹, Álvaro Peña¹, Esther Broset¹

¹Certest Pharma, Certest Biotec S.L., San Mateo de Gállego, 50840 Zaragoza, Spain.

|April 26, 2025

概括

研究人员为脂质纳米粒子 (LNP) 设计了新型可生物降解的电离性脂质 (IL),以精确地准mRNA输送的脏和肺部等器官. 结构修改可以控制生物分布,增强蛋白质表达,为向治疗铺平道路.

科学领域:

生物技术和纳米医学
药物输送系统药物输送系统
分子生物学分子生物学

背景情况:

脂质纳米颗粒 (LNP) 对于mRNA传递至关重要,有离子化脂质 (IL) 是关键组成部分.
了解IL结构和LNP器官向之间的关系对于优化输送至关重要.
生物降解ILs与β-propionate链接器被开发来改善LNP肝外选择性和蛋白质表达.

研究的目的:

调查ILs结构修改对LNP器官向和生物分布的影响.
在LNP配方中建立ILs的结构-功能关系,以实现精确的mRNA输送.
识别新型ILs以向特定器官,如脏和肺部.

主要方法:

合成并制定了一个可生物降解ILs的库,具有不同的疏水链和极点头组.
评估了LNP生物分布,器官特异性向和蛋白质表达水平 in vivo.
分析了蛋白质冠状形成,以获得对LNP向的机械洞察力.

主要成果:

ILs的结构性修改精确控制了脏和肺部之间的LNP生物分布.
分支的疏水链增强了脏向;极点头组修改将肺部转移到脏向.
鉴定了zeta潜力作为肝外向的关键决定因素;A3T2C7显示97%的肺选择性.

结论:

针对被动性,器官特异性mRNA传递的ILs的阐明结构-功能关系.
证明了微调IL结构 (疏水链,极点群,泽塔潜力) 控制LNP生物分布.
这些发现使得针对脏和肺部治疗应用的向LNP系统的合理设计成为可能.

关键词:

肝外分娩是如何进行的四个组成部分的LNP.可离子化脂质是可以离子化的脂质.脂质纳米颗粒的使用方法肺部准的目标是肺部.它们是mRNARNA.蛋白质冠状病毒冠状病毒脏准的目标是脏.

更多相关视频

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...